Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H L Tillmann

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
Journal of Viral Hepatitis|July 26, 2007
Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complicationsP Pradat, H L Tillmann, S Sauleda, et al.
Journal of Viral Hepatitis|April 14, 2006
Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experienceH L Tillmann, J Hadem, L Leifeld, et al.
Journal of Viral Hepatitis|December 17, 2013
Treatment of severe, nonfulminant acute hepatitis B with lamivudine vs placebo: a prospective randomized double-blinded multicentre trialJ Wiegand, H Wedemeyer, A Franke, et al.
Italian Journal of Gastroenterology and Hepatology|December 4, 1998
Efficacy of high dose of recombinant alpha 2b interferon on long term response in chronic hepatitis C and cirrhosis: prospective randomized multicentre studyA Ascione, M De Luca, C Canestrini, et al.
Journal of Viral Hepatitis|June 3, 2009
Autologous blood donor screening indicated a lower prevalence of viral hepatitis in East vs West Germany: epidemiological benefit from established health resourcesJ Wiegand, B Luz, A-K Mengelkamp, et al.
Journal of Viral Hepatitis|April 14, 2012
Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment responseP J Clark, A J Thompson, M Zhu, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
Journal of Viral Hepatitis|July 26, 2007
Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complicationsP Pradat, H L Tillmann, S Sauleda, et al.
Journal of Viral Hepatitis|April 14, 2006
Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experienceH L Tillmann, J Hadem, L Leifeld, et al.
Journal of Viral Hepatitis|December 17, 2013
Treatment of severe, nonfulminant acute hepatitis B with lamivudine vs placebo: a prospective randomized double-blinded multicentre trialJ Wiegand, H Wedemeyer, A Franke, et al.
Italian Journal of Gastroenterology and Hepatology|December 4, 1998
Efficacy of high dose of recombinant alpha 2b interferon on long term response in chronic hepatitis C and cirrhosis: prospective randomized multicentre studyA Ascione, M De Luca, C Canestrini, et al.
Journal of Viral Hepatitis|June 3, 2009
Autologous blood donor screening indicated a lower prevalence of viral hepatitis in East vs West Germany: epidemiological benefit from established health resourcesJ Wiegand, B Luz, A-K Mengelkamp, et al.
Journal of Viral Hepatitis|April 14, 2012
Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment responseP J Clark, A J Thompson, M Zhu, et al.
Pageof 10